Back to Search Start Over

TGF-[beta]-neutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung

Authors :
Nakanishi, Hidehiko
Sugiura, Takahiro
Streisand, James B.
Lonning, Scott M.
Roberts, Jesse D., Jr.
Source :
The American Journal of Physiology. July, 2007, Vol. 293 Issue 1, pL151, 11 p.
Publication Year :
2007

Abstract

Pulmonary injury is associated with the disruption of alveologenesis in the developing lung and causes bronchopulmonary dysplasia (BPD) in prematurely born infants. Transforming growth factor (TGF)-[beta] is an important regulator of cellular differentiation and early lung development, and its levels are increased in newborn lung injury. Although overexpression of TGF-[beta] in the lungs of newborn animals causes pathological features that are consistent with BPD, the role of endogenous TGF-[beta] in the inhibition of the terminal stage of lung development is incompletely understood. In this investigation, the hypothesis that [O.sub.2]-induced injury of the maturing lung is associated with TGF-[beta]-mediated disruption of alveologenesis and microvascular development was tested using a murine model of BPD. Here we report that treatment of developing mouse lungs with TGF-[beta]-neutralizing antibodies attenuates the increase in pulmonary cell phospho-Smad2 nuclear localization, which is indicative of augmented TGF-[beta] signaling, associated with pulmonary injury induced by chronic inhalation of 85% oxygen. Importantly, the neutralization of the abnormal TGF-[beta] activity improves quantitative morphometric indicators of alveologenesis, extracellular matrix assembly, and microvascular development in the injured developing lung. Furthermore, exposure to anti-TGF-[beta] antibodies is associated with improved somatic growth in hyperoxic mouse pups and not with an increase in pulmonary inflammation. These studies indicate that excessive pulmonary TGF-[beta] signaling in the injured newborn lung has an important role in the disruption of the terminal stage of lung development. In addition, they suggest that anti-TGF-[beta] antibodies may be an effective therapy for preventing some important developmental diseases of the newborn lung. bronchopulmonary dysplasia; transforming growth factor-[beta] doi:10.1152/ajplung.00389.2006

Details

Language :
English
ISSN :
00029513
Volume :
293
Issue :
1
Database :
Gale General OneFile
Journal :
The American Journal of Physiology
Publication Type :
Academic Journal
Accession number :
edsgcl.167107410